MOUNTAIN VIEW, Calif., Might 20, 2021 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical gadget firm centered on remodeling the lives of individuals affected by epilepsy, right this moment introduced it would report monetary outcomes for the primary quarter of 2021 earlier than market open on Thursday, June 3, 2021. The corporate’s administration will webcast a corresponding convention name starting at 5:00 a.m. Pacific Time /8:00 a.m. Japanese Time.
Buyers concerned about listening to the convention name could accomplish that by dialing (844) 955-2173 for home callers or (914) 987-7949 for worldwide callers, utilizing convention ID: 1485513. Stay audio of the webcast shall be out there on the “Buyers” part of the corporate’s web site at: https://buyers.neuropace.com. The webcast shall be archived and out there for replay for not less than 90 days after the occasion.
About NeuroPace, Inc.
Primarily based in Mountain View, Calif., NeuroPace is a commercial-stage medical gadget firm centered on remodeling the lives of individuals affected by epilepsy by lowering or eliminating the prevalence of debilitating seizures. Its novel and differentiated RNS System is the primary and solely commercially out there, brain-responsive neuromodulation platform that delivers personalised, real-time remedy on the seizure supply. This platform can drive a greater commonplace of take care of sufferers affected by drug-resistant epilepsy and has the potential to supply a extra personalised answer and improved outcomes to the big inhabitants of sufferers affected by different mind issues.
Matt Bacso, CFA